Large-scale testing (Phase 3)Study completedNCT05231590
What this trial is testing
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
Who this might be right for
COVID-19
Cinnagen 581